Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:15 PM
Ignite Modification Date:
2025-12-24 @ 5:15 PM
NCT ID:
NCT00780650
Eligibility Criteria:
Inclusion Criteria:
* Healthy individuals aged 18-50 years
* Type 1 Diabetes individuals aged 18-50 years
* BMI \<40 kg/m2
* Females of childbearing potential with negative urine pregnancy test
* Volunteers over 40 years of age, a cardiac stress test with no clinically significant conduction or ischemic changes
Exclusion Criteria:
The following groups of subjects will be excluded from the study:
* Pregnant women
* Subjects unable to give voluntary informed consent
* Subjects on anticoagulant drugs or with known bleeding diatheses
* Subjects with uncontrolled hypertension, heart disease, cerebrovascular incidents
* Subjects taking MAOIs
* Subjects with narrow angle glaucoma
* Subjects with diagnosed psychiatric disorders
* Subjects with allergy to atomoxetine, heparin, or lidocaine
Physical Exam Exclusion Criteria:
* Uncontrolled severe hypertension (i.e., blood pressure greater than 150/95)
* Clinically significant Cardiac Abnormalities (e.g. Heart Failure, Arrhythmias, ischemic tachycardia, S-T segment deviations, etc.) from history or from cardiac stress testing in subjects \> 40 years old.
* Pneumonia
* Hepatic Failure/Jaundice
* Renal Failure
* Acute Cerebrovascular/ Neurological deficit
* Fever greater than 38.0 C
Screening Laboratory Tests Exclusion Criteria Blood values as defined in protocol
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
50 Years
Study:
NCT00780650
Study Brief:
Protocol Section:
NCT00780650